Fludarabine Monotherapy Fails to Control a Case of Relapsing Non-Hodgkin’s Lymphoma
نویسنده
چکیده
Fludarabine (Fludara), a purine nucleoside analogue, is an antineoplastic drug that has been used in the treatment of many lymphoproliferative malignancies, including various types of non-Hodgkin's lymphoma (NHL). I report a patient who has suffered from a severe deterioration in his general condition after receiving Fludara as a single agent for relapsed NHL for which he’s received chemo-immunotherapy.
منابع مشابه
Extranodal Non-Hodgkin’s Lymphoma of the Oral Cavity: A Case Report
Lymphomas are solid malignant tumors having a wide spectrum of clinical and pathological features. Non-Hodgkin’s lymphoma (NHL) is a subtype of lymphoma with two-thirds of the cases presenting as lymph node enlargement. The remaining one third of NHL cases has been reported in the extranodal sites, including the gastro intestinal tract, Waldeyer’s ring, bone, skin, and brain. Intraoral non-Hodg...
متن کاملExtranodal Non-Hodgkin’s Lymphoma of the Oral Cavity Presenting as Gingival Swelling: A Case Report
Non-Hodgkin’s lymphoma is a heterogeneous malignancy originating from proliferation of lymphoid cells or their precursors. , we report a case of a 6-year-old Iranian male child admitted at the Department of Oral Medicine, School of Dentistry, Mashhad, Iran, in March 2019. The case was complaining about gingival swellings worsening for one month. Clinical and pathologic examination, comple...
متن کاملPharmacotherapy Update: Fludarabine in the Treatment of Non-Hodgkin’s Lymphoma
Fludarabine, a purine nucleoside analogue, is considered as the most active drug in chronic lymphocytic leukemia. This review summarizes current knowledge concerning the mechanism of action, pharmacological properties, clinical activity and toxicity of fl udarabine in the treatment of non-Hodgkin’s lymphoma. A literature search on fl udarabine for lymphomas was undertaken using MEDLINE database...
متن کاملJanuszewicz David Westerman Treatment - related myelodysplasia following fludarabine combination chemotherapy
Myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) are well-recognized complications of therapy with alkylating agents and topoisomerase II inhibitors. A recent comprehensive review of reported MDS/sAML rates concluded that up to 10% of patients treated for non-Hodgkin’s lymphoma (NHL) using either conventional dose alkylator-based regimens or high-dose therapy develop MDS or sAML...
متن کاملHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
Background: Non-Hodgkin lymphoma (NHL) includes a wide range of diseases with different clinical and biological features. NHL is usually presented as localized or generalized lymphadenopathy. It has been suggested that the HLA class I and II are associated with susceptibility to NHL. Different ethnic groups have been found to have different HLA class I and II alleles which affect NHL. Objective...
متن کامل